Home » Topics » Disease categories and therapies » Urology

Urology
RSS

BMS and Sanofi-Synthelabo withdraw irbesartan sNDA

Feb. 8, 2002

New series from Taisho inhibits 20-HETE production

Feb. 7, 2002

EMEA accepts vardenafil submission for treatment of ED

Feb. 6, 2002

Pharmacia licenses Nastech's nasally administered apomorphine for ED & FSD

Feb. 6, 2002

Curis reports evidence for a unique mechanism for the renal effects of BMP-7

Feb. 6, 2002

Highly effective antinephritic agent derived from linomide

Feb. 1, 2002

Preparation and use of new series of PDE5 inhibitors

Jan. 29, 2002

Chemokine CCR1 receptor antagonist effective in mouse model of renal fibrosis

Jan. 29, 2002

Vivus cleared to proceed with TA-1790 trial in erectile dysfunction

Jan. 22, 2002

Research snapshots in sexual dysfunction

Jan. 22, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...